EL
ATXI

EMFO LLC’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

EMFO LLC’s Portfolio ATXI Stock Details ATXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$28 Buy
8
+1
+14% +$6 ﹤0.01% 281
2024
Q1 		$79 Hold
7
– – ﹤0.01% 285
2023
Q4 		$86 Hold
7
– – ﹤0.01% 279
2023
Q3 		$377 Hold
7
– – ﹤0.01% 290
2023
Q2 		$624 Hold
7
– – ﹤0.01% 295
2023
Q1 		$621 Hold
7
– – ﹤0.01% 300
2022
Q4 		$618 Hold
7
– – ﹤0.01% 289
2022
Q3 		$5K Sell
7
-7
-50% -$2.24K ﹤0.01% 295
2022
Q2 		$4K Sell
14
-7
-33% -$2.7K ﹤0.01% 307
2022
Q1 		$12K Hold
21
– – 0.01% 277
2021
Q4 		$22K Sell
21
-18
-46% -$26K 0.02% 245
2021
Q3 		$65K Hold
39
– – 0.06% 182
2021
Q2 		$109K Buy
+39
New +$192K 0.1% 139

Other funds holding ATXI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EMFO LLC's ATXI Position: Q2 2024 in Review

EMFO LLC increased its Avenue Therapeutics, Inc. Common Stock (ATXI) stake by 14% in Q2 2024, buying an estimated $6 and bringing the position to 8 shares worth $28. The position accounts for ﹤0.01% of the portfolio, ranked #281.

EMFO LLC first reported a position in ATXI in Q2 2021 and has held it in 13 quarters since. The position peaked at $109K in Q2 2021. 9 funds tracked by Wall St. Rank hold ATXI as of Q2 2024.

  • EMFO LLC held 8 shares of Avenue Therapeutics, Inc. Common Stock worth $28 as of Q2 2024.
  • EMFO LLC bought 1 Avenue Therapeutics, Inc. Common Stock share in Q2 2024, an estimated $6.
  • Avenue Therapeutics, Inc. Common Stock made up ﹤0.01% of EMFO LLC's portfolio in Q2 2024, its #281 holding.
  • EMFO LLC first reported a position in Avenue Therapeutics, Inc. Common Stock in Q2 2021 and has held it in 13 quarters since.
  • EMFO LLC's Avenue Therapeutics, Inc. Common Stock position peaked at $109K in Q2 2021.
  • 9 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.